NovoCure NVCR Stock
$13.55
-7.255300%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$1.58B
LOW - HIGH [24H]
$13.49
-
$14.68
VOLUME [24H]
$1.70M
P/E Ratio
0
Earnings per share
-$1.06
ISIN
JE00BYSS4X48
NovoCure Price Chart
NovoCure NVCR Financial and Trading Overview
| NovoCure stock price | 13.55 USD |
| Previous Close | 14.61 USD |
| Open | 14.61 USD |
| Bid | 10.44 USD x 200 |
| Ask | 18.26 USD x 200 |
| Day's Range | 14.17 - 14.68 USD |
| 52 Week Range | 9.82 - 21.45 USD |
| Volume | 62.74K USD |
| Avg. Volume | 1.45M USD |
| Market Cap | 1.67B USD |
| Beta (5Y Monthly) | 1.084 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.06 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 25.71 USD |
NVCR Valuation Measures
| Enterprise Value | 1.48B USD |
| Trailing P/E | N/A |
| Forward P/E | -19.766603 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.295968 |
| Price/Book (mrq) | 4.5700994 |
| Enterprise Value/Revenue | 2.035 |
| Enterprise Value/EBITDA | -14.264 |
Trading Information
NovoCure Stock Price History
| Beta (5Y Monthly) | 1.084 |
| 52-Week Change | 29.63% |
| S&P500 52-Week Change | 14.40% |
| 52 Week High | 21.45 USD |
| 52 Week Low | 9.82 USD |
| 50-Day Moving Average | 15.58 USD |
| 200-Day Moving Average | 14.82 USD |
NVCR Share Statistics
| Avg. Volume (3 month) | 1.45M USD |
| Avg. Daily Volume (10-Days) | 2.11M USD |
| Shares Outstanding | 116.92M |
| Float | 96.89M |
| Short Ratio | 9.27 |
| % Held by Insiders | 9.91% |
| % Held by Institutions | 91.67% |
| Shares Short | 12.82M |
| Short % of Float | 14.81% |
| Short % of Shares Outstanding | 10.97% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | September 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -16.78% |
| Operating Margin (ttm) | -2.052% |
| Gross Margin | 77.25% |
| EBITDA Margin | -14.26% |
Management Effectiveness
| Return on Assets (ttm) | -6.79% |
| Return on Equity (ttm) | -35.18% |
Income Statement
| Revenue (ttm) | 725.39M USD |
| Revenue Per Share (ttm) | 6.32 USD |
| Quarterly Revenue Growth (yoy) | 15.69% |
| Gross Profit (ttm) | 560.38M USD |
| EBITDA | -103490000 USD |
| Net Income Avi to Common (ttm) | -121730000 USD |
| Diluted EPS (ttm) | -1.06 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 463.48M USD |
| Total Cash Per Share (mrq) | 3.96 USD |
| Total Debt (mrq) | 231.55M USD |
| Total Debt/Equity (mrq) | 66.04 USD |
| Current Ratio (mrq) | 2.488 |
| Book Value Per Share (mrq) | 3.117 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -722000 USD |
| Levered Free Cash Flow (ttm) | 9M USD |
Profile of NovoCure
| Country | United States |
| State | N/A |
| City | Baar |
| Address | Neuhofstrasse 21 |
| ZIP | 6340 |
| Phone | N/A |
| Website | https://www.novocure.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 1605 |
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
Q&A For NovoCure Stock
What is a current NVCR stock price?
NovoCure NVCR stock price today per share is 13.55 USD.
How to purchase NovoCure stock?
You can buy NVCR shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NovoCure?
The stock symbol or ticker of NovoCure is NVCR.
Which industry does the NovoCure company belong to?
The NovoCure industry is Medical Devices.
How many shares does NovoCure have in circulation?
The max supply of NovoCure shares is 116.92M.
What is NovoCure Price to Earnings Ratio (PE Ratio)?
NovoCure PE Ratio is now.
What was NovoCure earnings per share over the trailing 12 months (TTM)?
NovoCure EPS is -1.06 USD over the trailing 12 months.
Which sector does the NovoCure company belong to?
The NovoCure sector is Healthcare.
NovoCure NVCR included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
|
- | |||||
US Tech Composite
IXIC
US
|
24315 USD — |
-5.52
|
10.9B USD — | 24262.15 USD — | 25559.03 USD — | — - | 10.9B USD — |
|
US Tech US Smart Pharmaceuticals
NQSSPH
US
|
2289.66 USD — |
-3.88
|
— — | 2288.11 USD — | 2394.28 USD — | — - | — — |
|
US Tech AlphaDEX Multi Cap Growt
NQDXUSMLTCG
US
|
3606.55 USD — |
-5.41
|
— — | 3627.16 USD — | 3780.92 USD — | — - | — — |
|
US Tech Next Generation 100 Inde
NGX
US
|
1722.82 USD — |
-4.74
|
— — | 1727.42 USD — | 1797.59 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
7094.45 USD — |
-4.95
|
— — | 7088.39 USD — | 7457.55 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1358.39 USD — |
-4.53
|
— — | 1357.44 USD — | 1423.03 USD — | — - | — — |
|
US Tech Composite Total Return
XCMP
US
|
30040.43 USD — |
-5.52
|
— — | 29975.13 USD — | 31577.39 USD — | — - | — — |
|
US Tech Global Select Market Com
NQGS
US
|
11974.46 USD — |
-5.52
|
— — | 11947.73 USD — | 12586.4 USD — | — - | — — |
|
US Tech DM Ex Japan Large Mid Ca
NQDMXJPLMAUD
US
|
2100.38 AUD 1467.26 USD |
<0.01
|
— — | 2100.38 AUD 1467.26 USD | 2100.38 AUD 1467.26 USD | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
4000.62 USD — |
-1.26
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
